De Burlo Group Inc Abbott Laboratories Transaction History

De Burlo Group Inc

$808 Million
Q3 2024

A detailed history of De Burlo Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, De Burlo Group Inc holds 9,833 shares of ABT stock, worth $1.12 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

9,833

Previous 13,033 24.55%

Holding current value

$1.12 Million

Previous $1.35 Million 17.21%

% of portfolio

0.14%

Previous 0.18%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $320,224 - $378,016	-3,200 Reduced 24.55%	9,833 $1.12 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $135,985 - $151,794	-1,350 Reduced 9.39%	13,033 $1.35 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $109,520 - $120,960	-1,000 Reduced 6.5%	14,383 $1.63 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $62,094 - $74,503	-650 Reduced 4.05%	15,383 $1.49 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $20,156 - $22,458	-200 Reduced 1.23%	16,033 $1.75 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $19,012 - $22,304	-200 Reduced 1.22%	16,233 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $930,831 - $1.08 Million	9,620 Added 141.2%	16,433 $1.59 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $997,223 - $1.21 Million	-9,770 Reduced 58.92%	6,813 $740,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $10.8 Million - $13.2 Million	-95,000 Reduced 85.14%	16,583 $1.96 Million
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $1.07 Million - $1.32 Million	9,300 Added 9.09%	111,583 $15.7 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $9.96 Million - $11 Million	85,400 Added 505.83%	102,283 $12.1 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $12.8 Million - $15.1 Million	-121,100 Reduced 87.76%	16,883 $1.96 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $2.55 Million - $3 Million	23,400 Added 20.42%	137,983 $16.5 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $3.35 Million - $3.66 Million	-31,950 Reduced 21.8%	114,583 $12.5 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $13 Million - $15.8 Million	141,933 Added 3085.5%	146,533 $15.9 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $25,128 - $36,744	-400 Reduced 8.0%	4,600 $363,000
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $16,368 - $17,748	200 Added 4.17%	5,000 $418,000
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $276,336 - $304,992	4,800 New	4,800 $292,000
Q1 2018 May 03, 2018	SELL	$56.27 - $63.62 $270,096 - $305,376	-4,800 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $230,688 - $257,472	4,800	4,800 $256,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account

De Burlo Group Inc Abbott Laboratories Transaction History